Attached files

file filename
10-K - 10-K - CASSAVA SCIENCES INCptie-20171231x10k.htm
EX-32.1 - EX-32.1 - CASSAVA SCIENCES INCptie-20171231xex32_1.htm
EX-31.1 - EX-31.1 - CASSAVA SCIENCES INCptie-20171231xex31_1.htm
EX-10.17 - EX-10.17 - CASSAVA SCIENCES INCptie-20171231xex10_17.htm

EXHIBIT 23.1





Consent of Independent Registered Public Accounting Firm





We consent to the incorporation by reference in the Registration Statements (Forms S-3 No. 333-217319) of Pain Therapeutics, Inc. and in the related Prospectus, and in the Registration Statements (Form S-8 No. 333-168390) 2000 Employee Stock Purchase Plan of Pain Therapeutics, Inc. of our report dated February 6, 2018, with respect to the financial statements of Pain Therapeutics, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2017.



/s/Ernst &Young LLP



Austin, Texas

February 6, 2018